维普中文期刊产品整合服务

An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options

查看全文 作  者:Anne [1]Masi;Marilena M.De [1]Mayo;Nicholas [1]Glozier;Adam [1]J.Guastella 高影响力作者 机构地区:[1]Autism Clinic for Translational Research, Brain and Mind Centre, Central Clinical School, Sydney Medical School,University of Sydney高影响力机构 出  处:《Neuroscience Bulletin》索引2017年第33卷第2期,共11页高影响力期刊 基  金:a NHMRC career development fellowship (APP1061922);a Project Grant (1043664) to Adam J. Guastella 摘  要:Since the documented observations of Kanner in1943, there has been great debate about the diagnoses, the sub-types, and the diagnostic threshold that relates to what is now known as autism spectrum disorder(ASD).Re?ecting this complicated history, there has been continual re?nement from DSM-III with ‘Infantile Autism' to the current DSM-V diagnosis. The disorder is now widely accepted as a complex, pervasive, heterogeneous condition with multiple etiologies, sub-types, and developmental trajectories. Diagnosis remains based on observation of atypical behaviors, with criteria of persistent de?cits in social communication and restricted and repetitive patterns of behavior. This review provides a broad overview of the history, prevalence, etiology, clinical presentation, and heterogeneity of ASD. Factors contributing to heterogeneity, including genetic variability, comorbidity, and gender are reviewed. We then explore current evidencebased pharmacological and behavioral treatments for ASD and highlight the complexities of conducting clinical trials that evaluate therapeutic ef?cacy in ASD populations.Finally, we discuss the potential of a new wave of research examining objective biomarkers to facilitate the evaluation of sub-typing, diagnosis, and treatment response in ASD. 关 键 词:Autism Spectrum Disorder DIAGNOSIS HETEROGENEITY TREATMENT
相关文献

参考文献(126)

引证文献(40)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费